focus -WSS

focus

author：focus 2025-09-29 18:18:20 - browse：78593

A photograph of someone preparing small petri dishes, each holding several 1-7 day old embryos, for cells to be extracted from each embryo to test for viability at an in vitro fertilization lab — In vitro fertilization lab staff prepare small petri dishes, each holding embryos. (This sample image doesn't necessarily show embryos grown in media from CooperSurgical, a supply giant now facing lawsuits.) Michael Wyke/AP

Patients from all over the country are filing lawsuits against medical supply giant CooperSurgical, alleging that fluid the company sent to in vitro fertilization clinics destroyed their embryos.

The fluid, called culture media, is filled with nutrients that allow embryos to develop enough to ultimately be implanted into a uterus. CooperSurgical acknowledged that the batch of fluid may have stunted embryo growth in a product recall notice, but it hasn’t disclosed exactly what went wrong. Lawsuits claim the media lacked magnesium, a key nutrient, while a Cooper representative told STAT the cause is still under investigation.

The recall could be a one-off manufacturing fluke. But the debacle, and the uncertainty around the problems with the fluid, sheds light on a larger problem: IVF doctors rarely know the exact composition of culture media in the first place. The Food and Drug Administration asks manufacturers for a list of materials before the media goes on the market, an FDA spokesperson told STAT. Companies will sometimes give clinics this information voluntarily, along with required labeling information like mouse embryo data, instructions for use, and warnings. But the FDA doesn’t require companies to list the ingredients or their proportions publicly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Weighted lottery helped low

hotspot

knowledge

WSS

NEJM study link tiny plastics in blood vessels to heart problems

AstraZeneca chief proposes a novel edit to the drug pricing bill

Advances in CAR

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

What drug price negotiations mean for Medicare Part D

Stem cell treatment guidelines are released by FDA

focus

focus

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

The Readout: Amylyx, Alumis, and Lundbeck drug updates

How to save PrEP access — and even expand it

UnitedHealth quietly bought dozens of outpatient centers

Walensky prepares to leave CDC — and Congress — behind

The Readout: Amylyx, Alumis, and Lundbeck drug updates

At least 13 dead in Texas as scorching temps continue

How to protect patients from sexual assault

In age of alternative facts, a scholarly course on calling out crap

Change Healthcare payments predicted restored March 15

focus

How generative AI is inspiring dreams of a health data revolution

Sen. Paul opposes bill to ban Chinese biotechs

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

AstraZeneca chief proposes a novel edit to the drug pricing bill

The drug industry has found itself all alone in Washington

In his State of the Union, Biden takes clear aim at 'Big Pharma'

hotspot

knowledge

hotspot

hotspot